

| »áÕ¹Ãû³Æ | 2011Äê¹ú¼ÊTϸ°ûÁܰÍÁöÂÛ̳£¨TLF£© |
| ²¼Õ¹Ê±¼ä | 2011Äê1ÔÂ26ÈÕ |
| Õ¹ÀÀʱ¼ä | 2011Äê1ÔÂ27ÈÕ—2011Äê1ÔÂ29ÈÕ |
| ³·Õ¹Ê±¼ä | 2011Äê1ÔÂ30ÈÕ |
| »áÕ¹³¡¹Ý |
¾É½ðɽ |
| Ö÷°ìµ¥Î» | |
| ³Ð°ìµ¥Î» | |
| а쵥λ | |
| »áÕ¹Àà±ð | |
| ËùÔÚµØÇø |
ÃÀ¹ú ¾É½ðɽ |
| »áÕ¹ÃèÊö |
This forum will provide a platform for discussion about the classification, epidemiology, prognosis, and pathogenesis of several T-cell lymphoma subtypes. In addition, the latest information on novel agents and treatment approaches will be presented by T-cell lymphoma experts. This meeting is intended for hematologists, oncologists, and other clinicians and scientists with an interest in T-cell lymphoma. |
| ²ÎÕ¹·ÑÓà |
¡¡ |
| ¹ã¸æ·ÑÓà |
¡¡ |
| Õ¹»áÖÜÆÚ |
ÿÄêÒ»½ì |
| Õ¹»á¹æÄ£ |
¡¡ |
| ×¢ÒâÊÂÏî |
|
| ÁªÏµ·½Ê½ |
×Éѯµç»°: 8610-66054455 8610-51294800 |